期刊文献+

铜、锌及铜氧化酶含量与肝豆状核变性的关系 被引量:1

Connection Between the Content of Copper,Zinc,Copper-oxygenase and Wilson Disease
下载PDF
导出
摘要 目的探讨微量元素铜、锌及铜氧化酶含量与肝豆状核变性诊断及治疗转归的关系及临床意义。方法采用火焰原子吸收分光光度法测定肝豆状核变性患者的血清中微量元素铜、锌含量和尿中铜的含量;采用可见分光光度法测定铜氧化酶的含量。结果肝豆状核变性患者年龄为7~51岁(平均22.5±8.85岁),实验室检查和门诊初步诊断相比,铜氧化酶<0.21IU的确诊率为75.27%,血铜<10μmol·L-1的确诊率为66.67%,血锌<11.6μmol·L-1的确诊率为28.89%,治疗后尿铜含量差异非常显著(P<0.01)。结论血铜含量及铜氧化酶含量对肝豆状核变性确诊有良好的指导意义,尿铜含量可帮助医生对临床疗效转归和用药选择做出正确评价。 Objective To explore the relationship and clinical meaning between trace chemical elements such as copper, zinc, copper-oxygenase and wilson (WD), diagnosis and treatment. Methods The authors used flame atomic absorption spectrophotometry to measure the content of copper and zinc in WD sufferer' s serum and copper in urine, and the content of copper-oxygenase was determined by visible spectrophotometry. Results As to the WD sufferer' s outbreak aged in 7 - 51 (22.5 ± 8.85), the laboratory check was comoared with policlic initiative and the diagnosis corresponding rate of copper-oxygenase was 〈 0.21IU 75.27 %, the diagnosis corresponding rate of copper was 〈 10umol/L 66.67%, the diagnosis corresponding rate of serum zinc was 〈 11.6umol/L 28.89%, there was statistically significant difference in the content of copper compard with the state before and after treatment( P 〈 0.01 ). Conclusion The content of serum copper and copper-oxygenase is of meaningful. The content assay of urine copper can help doctors choose drug and come to right evaluation.
出处 《河南职工医学院学报》 2005年第3期133-135,共3页 Journal of Henan Medical College For Staff and Workers
关键词 铜氧化酶 含量测定 火焰原子吸收分光光度法 可见分光光度法 copper zinc copper-oxygenase content assay flame atomic absorption spectrophotometry visible spectrophotometry
  • 相关文献

参考文献6

二级参考文献22

共引文献210

同被引文献11

  • 1贾建平.神经病学.6版.北京:人民卫生出版社,2008:187.
  • 2Pfeiffer RF. Wilson's disease. Semin Neurol, 2007, 27(2) : 123-132.
  • 3European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol, 2012, 56 (3): 671-685.
  • 4Schilsky ML. Wilson's disease: new insights into patho- genesis, diagnosis, and future therapy. Curr Gastroen- terol Rep, 2005, 7 (1): 26-31.
  • 5Takahashi H, Ono N, Eguchi Y, Eguchi T, Kitajima Y, Kawaguchi Y, Nakashita S, Ozaki I, Mizuta T, To- da S, Kudo S, Miyoshi A, Miyazaki K, Fujimoto K. E- valuation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot stud- y. Liver Int, 2010, 30 (4): 538-545.
  • 6Bahnson TD, Eyerly SA, Hollender P~, Doherty ~R, Kim Y J, Trahey GE, Wolf PD. Feasibility of near real- time lesion assessment during radiofrequency catheter ablation in humans using acoustic radiation force impulse imaging. J Cardiovasc Electrophysiol, 2014, 25 (12) : 1275-1283.
  • 7杨任民.肝豆状核变性的治疗[J].中国实用儿科杂志,2000,15(2):79-80. 被引量:24
  • 8王艳昕,鲍远程,蔡永亮,侯志峰,许珍晶,徐磊,徐明安,马守亮.肝豆状核变性的肝脏病理及超微结构研究进展[J].中医药临床杂志,2013,25(3):252-255. 被引量:8
  • 9苏中振,郑荣琴.超声新技术在肝脏疾病诊断及治疗中的应用[J].新医学,2013,44(10):663-666. 被引量:7
  • 10王金萍,李保启,陈晓艺,许红强,常丽娜,伍宏兵.声触诊组织量化技术在肝豆状核变性患者肝脏受损评价中的应用[J].蚌埠医学院学报,2013,38(11):1473-1475. 被引量:2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部